OncoSec Medical Incorporated announced the appointment of Bridget O'Keeffe, as Vice President of Clinical Development effective February 18, 2021. Dr. O'Keeffe most recently served as Senior Director of Clinical Development for Nektar Therapeutics, where she built and trained an oncology clinical science team and provided clinical development leadership in the development of company processes and policy through interdepartmental, company-wide committees, working groups and initiatives.